Page last updated: 2024-12-06

dispersion yellow 3

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Dispersion Yellow 3: used in carpet industry; river pollutant [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

4-(2-hydroxy-5-methylphenylazo)acetanilide : An azo dye with a structure consisting of acetanilide substituted on the 4-position of the phenyl group with a 6-hydroxy-m-tolylazo group. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID17811
CHEMBL ID1590721
CHEBI ID53617
SCHEMBL ID108928
SCHEMBL ID2867995
MeSH IDM0083768

Synonyms (163)

Synonym
acetamide, n-[4-[(2-hydroxy-5-methylphenyl)azo]phenyl]-
disperse yellow 3,ci 11855
c.i. 11855
c.i. disperse yellow 3
2832-40-8
n-{4-[(e)-(2-hydroxy-5-methylphenyl)diazenyl]phenyl}acetamide
ci solvent yellow 77
microsetile yellow gr
nacelan fast yellow cg
serisol fast yellow gd
resiren yellow tg
safaritone yellow g
perliton yellow g
dispersol fast yellow g
hisperse yellow g
terasil yellow gba extra
tertranese yellow n-2gl
4-(2-hydroxy-5-methylphenylazo)acetanilide
zlut disperzni 3 [czech]
altco sperse fast yellow gfn new
4-acetamido-2'-hydroxy-5'-methylazobenzene
celutate yellow gh
setacyl yellow p-2gl
disperse yellow z
tuladisperse fast yellow 2g
esteroquinone light yellow 4jl
c.i. solvent yellow 77
vonteryl yellow g
artisil yellow 2gn
nyloquinone light yellow 4jl
miketon fast yellow g
amacel yellow g
n-(4-((2-hydroxy-5-methylphenyl)azo)phenyl)acetamide
hispacet fast yellow g
celliton yellow g
ccris 169
dispersol yellow a-g
palanil yellow g
terasil yellow 2gc
kayalon fast yellow g
ci solvent yellow 14 cytembena
kayaset yellow g
calcosyn yellow gcn
serinyl hosiery yellow gd
celliton fast yellow ga-cf
c.i. 3/11855
eastone yellow gn
estone yellow gn
dispersion yellow 3
acetoquinone light yellow
cibacet yellow 2gc
ci solvent yellow 99
acetoquinone light yellow 4jlz
setacyl yellow 2gn
disperse fast yellow g
dispersive yellow 3t
palacet yellow gn
vonteryl yellow r
silotras yellow tsg
calcosyn yellow gc
fenacet yellow g
reliton yellow c
pamacel yellow g-3
nyloquinone yellow 4j
atrisil direct yellow g
dispersol printing yellow g
diacelliton fast yellow g
4'-((6-hydroxy-m-tolyl)azo)acetanilide
cellutate yellow gh
celliton discharge yellow gl
interchem hisperse yellow gh
acetate fast yellow g
artisil direct yellow g
cibacete yellow gba
interchem disperse yellow gh
seriplas yellow gd
disperse yellow g
synten yellow 2g
acetamide, n-(4-((2-hydroxy-5-methylphenyl)azo)phenyl)-
brn 0753492
interchem acetate yellow g
artisil yellow g
cibacet yellow gba
n-[4-[(2-hydroxy-5-methylphenyl)azo]phenyl]acetamide
acetamine yellow cg
intrasperse yellow gba extra
ci 11855
nci-c53781
fenacet fast yellow g
einecs 220-600-8
genacron yellow g
ci solvent yellow 92
cilla fast yellow g
novalon yellow 2gn
ci disperse yellow 3
kca acetate fast yellow g
yellow z
setacyl yellow g
disperse yellow 3
supracet fast yellow g
synton yellow 2g
celliton fast yellow g
celliton fast yellow ga
yellow reliton g
zlut rozpoustedlova 77 [czech]
durgacet yellow g
samaron yellow pa3
durosperse yellow g
hsdb 4096
intraperse yellow gba
ostacet yellow p2g
acetamide, n-(4((2-hydroxy-5-methylphenyl)azo)phenyl)-
disperse yellow 3, dye content 30 %
NCGC00164349-01
CHEBI:53617 ,
n-[4-[2-(2-hydroxy-5-methylphenyl)diazenyl]phenyl]-acetamide
n-[4-[(2e)-2-(3-methyl-6-oxocyclohexa-2,4-dien-1-ylidene)hydrazinyl]phenyl]acetamide
C19412
unii-0890872e2e
zlut rozpoustedlova 77
0890872e2e ,
zlut disperzni 3
acetamide, n-(4-(2-(2-hydroxy-5-methylphenyl)diazenyl)phenyl)-
AKOS024319575
EPITOPE ID:116060
AKOS015903469
c.i.-11855
ci disperse yellow 3 [hsdb]
disperse yellow 3 [iarc]
ci-11855
c.i. solvent yellow 99
c.i. solvent yellow 92
AKOS025295054
SCHEMBL108928
SCHEMBL2867995
CHEMBL1590721
lurafix yellow 142
PXOZAFXVEWKXED-ISLYRVAYSA-N
n-(4-[2-(2-hydroxy-5-methylphenyl)diazenyl]phenyl)acetamide
acetanilide, 4'-(6-hydroxy-m-tolylazo)-
transetile yellow p-gr
acetamide, n-[4-[2-(2-hydroxy-5-methylphenyl)diazenyl]phenyl]-
cibacet yellow 2gc150
4'-[(2-hydroxy-5-methylphenyl)azo]acetanilide
cas-2832-40-8
NCGC00357249-01
dtxsid6021450 ,
tox21_304042
dtxcid401450
W-109827
n-[4-[(2-oh-5-methylphenyl)azo]phenyl]acetamide
mfcd00002377
disperse yellow 3, analytical standard
solvent yellow 77
Q27032530
n-(4-((2-hydroxy-5-methylphenyl)diazenyl)phenyl)acetamide
disperse yellow 3, tech.
A11779
n-[4-[(2-hydroxy-5-methylphenyl)diazenyl]phenyl]acetamide
1032589-83-5
(e)-n-(4-((2-hydroxy-5-methylphenyl)diazenyl)phenyl)acetamide
(e)-n-{4-[(2-hydroxy-5-methylphenyl)diazenyl]phenyl}acetamide
DTXSID80859775
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (24)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
LuciferasePhotinus pyralis (common eastern firefly)Potency3.17060.007215.758889.3584AID1224835
acetylcholinesteraseHomo sapiens (human)Potency22.44580.002541.796015,848.9004AID1347397
hypoxia-inducible factor 1 alpha subunitHomo sapiens (human)Potency61.64483.189029.884159.4836AID1224846
RAR-related orphan receptor gammaMus musculus (house mouse)Potency4.22760.006038.004119,952.5996AID1159521; AID1159523
GLI family zinc finger 3Homo sapiens (human)Potency17.30510.000714.592883.7951AID1259368; AID1259369; AID1259392
AR proteinHomo sapiens (human)Potency5.35000.000221.22318,912.5098AID1259243; AID1259247; AID1259381
caspase 7, apoptosis-related cysteine proteaseHomo sapiens (human)Potency13.68540.013326.981070.7614AID1346978
nuclear receptor subfamily 1, group I, member 3Homo sapiens (human)Potency1.76670.001022.650876.6163AID1224838; AID1224839; AID1224893
progesterone receptorHomo sapiens (human)Potency48.55770.000417.946075.1148AID1346795
retinoic acid nuclear receptor alpha variant 1Homo sapiens (human)Potency1.29320.003041.611522,387.1992AID1159552; AID1159555
estrogen-related nuclear receptor alphaHomo sapiens (human)Potency5.52370.001530.607315,848.9004AID1224841; AID1224842; AID1224848; AID1224849; AID1259401; AID1259403
farnesoid X nuclear receptorHomo sapiens (human)Potency50.11870.375827.485161.6524AID588526
pregnane X nuclear receptorHomo sapiens (human)Potency22.58490.005428.02631,258.9301AID1346982; AID720659
estrogen nuclear receptor alphaHomo sapiens (human)Potency2.83950.000229.305416,493.5996AID1259244; AID1259248
peroxisome proliferator activated receptor gammaHomo sapiens (human)Potency50.11870.001019.414170.9645AID588536
caspase-3Homo sapiens (human)Potency13.68540.013326.981070.7614AID1346978
aryl hydrocarbon receptorHomo sapiens (human)Potency4.46680.000723.06741,258.9301AID651777
thyroid stimulating hormone receptorHomo sapiens (human)Potency9.68850.001628.015177.1139AID1259385
v-jun sarcoma virus 17 oncogene homolog (avian)Homo sapiens (human)Potency0.17370.057821.109761.2679AID1159528
thyroid hormone receptor beta isoform aHomo sapiens (human)Potency79.43280.010039.53711,122.0200AID1479
histone deacetylase 9 isoform 3Homo sapiens (human)Potency2.89720.037617.082361.1927AID1259364; AID1259388
nuclear factor erythroid 2-related factor 2 isoform 1Homo sapiens (human)Potency9.97980.000627.21521,122.0200AID651741; AID720636
Voltage-dependent calcium channel gamma-2 subunitMus musculus (house mouse)Potency2.43370.001557.789015,848.9004AID1259244
Glutamate receptor 2Rattus norvegicus (Norway rat)Potency2.43370.001551.739315,848.9004AID1259244
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Ceullar Components (1)

Processvia Protein(s)Taxonomy
plasma membraneGlutamate receptor 2Rattus norvegicus (Norway rat)
[Information is prepared from geneontology information from the June-17-2024 release]

Research

Studies (13)

TimeframeStudies, This Drug (%)All Drugs %
pre-19904 (30.77)18.7374
1990's3 (23.08)18.2507
2000's1 (7.69)29.6817
2010's5 (38.46)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.36

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.36 (24.57)
Research Supply Index2.77 (2.92)
Research Growth Index5.13 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.36)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (6.67%)6.00%
Case Studies2 (13.33%)4.05%
Observational0 (0.00%)0.25%
Other12 (80.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]